Vascular Biogenics Ltd.(NASDAQ : VBLT)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|VRTX||Vertex Pharmaceuticals, Inc.||-0.30%||207.82||1.9%||$517.32m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.50%||448.98||2.7%||$505.72m|
|GILD||Gilead Sciences, Inc.||1.64%||63.78||1.0%||$487.94m|
|ALXN||Alexion Pharmaceuticals, Inc.||-0.05%||148.11||2.0%||$341.34m|
|CRSP||CRISPR Therapeutics AG||-4.49%||113.73||0.6%||$270.22m|
|BNGO||Bionano Genomics, Inc.||-20.94%||6.76||0.0%||$239.07m|
|EXAS||EXACT Sciences Corp.||-5.26%||119.91||18.4%||$223.62m|
|PACB||Pacific Biosciences of California, Inc.||-7.57%||28.62||7.2%||$151.42m|
Vascular Biogenics Ltd. is in the clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of first-in-class treatments for cancer. Its programs include cancer, inflammation, and VB-600 which are focused on treating tumors, ovarian cancer, and chronic immune-related indications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.